↓ Skip to main content

Dove Medical Press

The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats

Overview of attention for article published in Neuropsychiatric Disease and Treatment, September 2008
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
20 Mendeley
Title
The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats
Published in
Neuropsychiatric Disease and Treatment, September 2008
DOI 10.2147/ndt.s3272
Pubmed ID
Authors

Haris Carageorgiou, Antonios C Sideris, Ioanna Messari, Chrissoula I Liakou, Stylianos Tsakiris

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 5%
Unknown 19 95%

Demographic breakdown

Readers by professional status Count As %
Other 3 15%
Researcher 3 15%
Student > Bachelor 3 15%
Lecturer 2 10%
Student > Doctoral Student 2 10%
Other 2 10%
Unknown 5 25%
Readers by discipline Count As %
Agricultural and Biological Sciences 4 20%
Psychology 2 10%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Business, Management and Accounting 1 5%
Other 3 15%
Unknown 8 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 September 2023.
All research outputs
#8,535,472
of 25,374,917 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,152
of 3,132 outputs
Outputs of similar age
#35,137
of 95,712 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#12
of 21 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,712 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.